AIBL International, the latest addition to the Tecan Group, offers a range of microplate-based immunoassays to help diagnose Alzheimer’s disease, a devastating condition that significantly impacts the lives of both sufferers and their families. Early diagnosis is essential for implementation of appropriate treatment and support mechanisms, enabling patients to live as independently as possible.

read full article

Manually related articles